Kailera Therapeutics, Inc. (KLRA)

11.99 -0.84 (-6.55%) USD  |  NASDAQ  |  Sep 21, 16:00
12.16 +0.17 (+1.42%) After-Hours: 20:00
More

Kailera Therapeutics EPS Diluted (Quarterly) : -0.8587 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 -0.8587
March 31, 2026 -0.6087
Date Value
June 30, 2025 -0.2233

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. -1.355
Oncolytics Biotech, Inc. -0.0788
Sangamo Therapeutics, Inc. -0.0796
Sarepta Therapeutics, Inc. -0.0464
Anixa Biosciences, Inc. -0.0762

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -111.31M
Total Expenses (Quarterly) 111.31M
Enterprise Value 647.62M
Earnings Yield -14.10%